Indication · Neurology & Neurosurgery
Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
264
Cleared or approved since 2000
PMA and De Novo
18
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
47
287 device trials in all
Devices
17 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Woven EndoBridge Aneurysm Embolization (WEB) System
MicroVention, Inc. · PMA · Intrasaccular Flow Disruption Device · newest 2026 · 9 decisions
16 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB DeviceActive, not recruiting
Microvention-Terumo, Inc.Public (4543.T)
NCT04839705 · 200 participants (planned) · Start Aug 24, 2022 · Primary completion May 8, 2027
Device: WEB · For: Wide Neck Bifurcation Intracranial Aneurysms
Sites: Hollywood, Florida; Orlando, Florida; Honolulu, Hawaii · 27 sites in all
286 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Device, Neurovascular Embolization (HCG)100
- Catheter, Percutaneous, Neurovasculature (QJP)84
- Guide, Wire, Catheter, Neurovasculature (MOF)36
- Clip, Aneurysm (HCH)17
- Intracranial Aneurysm Flow Diverter (OUT)8
- Applier, Aneurysm Clip (HCI)4
- Software For Visualization Of Vascular Anatomy And Intravascular Devices (PZO)4
- Intracranial Coil-Assist Stent (QCA)3
- Neurovascular Liquid Embolic Agent (SGU)3
- Agent, Injectable, Embolic (MFE)2
- Methyl Methacrylate For Aneurysmorrhaphy (JXH)1
- Intrasaccular Flow Disruption Device (OPR)1
- Temporary Coil Embolization Assist Device (PUU)1
Research
- Device studies on intracranial aneurysm across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.